These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 32471869)

  • 1. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.
    Min YQ; Ning YJ; Wang H; Deng F
    J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
    Ban J; Lee NR; Lee NJ; Lee JK; Quan FS; Inn KS
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.
    Atkinson SC; Heaton SM; Audsley MD; Kleifeld O; Borg NA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses.
    Santiago FW; Covaleda LM; Sanchez-Aparicio MT; Silvas JA; Diaz-Vizarreta AC; Patel JR; Popov V; Yu XJ; García-Sastre A; Aguilar PV
    J Virol; 2014 Apr; 88(8):4572-85. PubMed ID: 24478431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
    Oshiumi H; Miyashita M; Matsumoto M; Seya T
    PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonstructural Protein of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Inhibits TBK1 to Evade Interferon-Mediated Response.
    Lee JK; Shin OS
    J Microbiol Biotechnol; 2021 Feb; 31(2):226-232. PubMed ID: 33397830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25.
    Pauli EK; Chan YK; Davis ME; Gableske S; Wang MK; Feister KF; Gack MU
    Sci Signal; 2014 Jan; 7(307):ra3. PubMed ID: 24399297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Conserved Amino Acids within the NSs of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Are Essential for Anti-interferon Activity.
    Moriyama M; Igarashi M; Koshiba T; Irie T; Takada A; Ichinohe T
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot-and-Mouth Disease Virus 3B Protein Interacts with Pattern Recognition Receptor RIG-I to Block RIG-I-Mediated Immune Signaling and Inhibit Host Antiviral Response.
    Zhang X; Zhu Z; Wang C; Yang F; Cao W; Li P; Du X; Zhao F; Liu X; Zheng H
    J Immunol; 2020 Oct; 205(8):2207-2221. PubMed ID: 32917788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling.
    Sánchez-Aparicio MT; Feinman LJ; García-Sastre A; Shaw ML
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses.
    Hayman TJ; Hsu AC; Kolesnik TB; Dagley LF; Willemsen J; Tate MD; Baker PJ; Kershaw NJ; Kedzierski L; Webb AI; Wark PA; Kedzierska K; Masters SL; Belz GT; Binder M; Hansbro PM; Nicola NA; Nicholson SE
    Immunol Cell Biol; 2019 Oct; 97(9):840-852. PubMed ID: 31335993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.
    Shu XS; Zhao Y; Sun Y; Zhong L; Cheng Y; Zhang Y; Ning K; Tao Q; Wang Y; Ying Y
    J Pathol; 2018 Jan; 244(1):36-48. PubMed ID: 28940253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.
    Rajsbaum R; Albrecht RA; Wang MK; Maharaj NP; Versteeg GA; Nistal-Villán E; García-Sastre A; Gack MU
    PLoS Pathog; 2012; 8(11):e1003059. PubMed ID: 23209422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I.
    Zhao C; Jia M; Song H; Yu Z; Wang W; Li Q; Zhang L; Zhao W; Cao X
    Cell Rep; 2017 Nov; 21(6):1613-1623. PubMed ID: 29117565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction.
    Ning YJ; Feng K; Min YQ; Deng F; Hu Z; Wang H
    J Biol Chem; 2017 Oct; 292(40):16722-16733. PubMed ID: 28848048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform.
    Ning YJ; Wang M; Deng M; Shen S; Liu W; Cao WC; Deng F; Wang YY; Hu Z; Wang H
    J Mol Cell Biol; 2014 Aug; 6(4):324-37. PubMed ID: 24706939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Underlying Interaction Mechanism Between
    Zhou CM; Yu XJ
    Front Immunol; 2021; 12():676861. PubMed ID: 34122440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.